Table 3 Odds ratios (ORs) and confidence intervals (CIs) of ovarian cancer in association with prevalent co-morbidities by histology groups
From: Evaluation of prevalent and incident ovarian cancer co-morbidity
High-risk epithelial tumours a | Medium-risk epithelial tumours b | |||||
|---|---|---|---|---|---|---|
Cases ( n =8567)/controls ( n =42 835) | OR | 95% CI | Cases (1504)/controls ( n =7518) | OR | 95% CI | |
Haematologic complications | 388/592 | 3.4 | (3.0–3.9) | 66/86 | 3.9 | (2.8–5.4) |
Thyroid disease | 201/485 | 2.1 | (1.8–2.5) | 28/78 | 1.8 | (1.2–2.8) |
Cardiovascular disease | 818/3498 | 1.2 | (1.1–1.3) | 106/494 | 1.1 | (0.9–1.4) |
Cerebrovascular event | 268/1433 | 0.9 | (0.8–1.1) | 44/180 | 1.2 | (0.9–1.7) |
Thromboembolic events | 267/566 | 2.4 | (2.1–2.8) | 58/105 | 2.9 | (2.1–4.0) |
Hypertension | 862/2206 | 2.1 | (2–2.3) | 133/307 | 2.4 | (1.9–2.9) |
Pulmonary disease | 123/584 | 1.1 | (0.9–1.3) | 15/72 | 1.0 | (0.6–1.8) |
GI complications | 743/1937 | 2.0 | (1.9–2.2) | 116/281 | 2.2 | (1.7–2.8) |
Diabetes mellitus | 343/1143 | 1.5 | (1.4–1.7) | 58/143 | 2.1 | (1.5–2.9) |
Liver/pancreatic disease | 110/363 | 1.5 | (1.2–1.9) | 25/65 | 1.9 | (1.2–3.1) |
Urinary tract complications | 43/124 | 1.7 | (1.2–2.5) | 7/19 | 1.9 | (0.8–4.4) |
Infectious complications | 539/1513 | 1.8 | (1.7–2.0) | 83/226 | 1.9 | (1.5–2.5) |
Neoplasms | 691/1988 | 1.8 | (1.7–2.0) | 128/310 | 2.2 | (1.8–2.7) |
